Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Oden6570on Jun 20, 2024 3:03am
148 Views
Post# 36097288

RE:RE:My Thoughts

RE:RE:My Thoughts
CancerSlayer wrote:
2b7f6fab wrote:
My Thoughts, having first bought shares way back in 2012.
 
I listened to the after AGM presentation.  I know it's been a long hard slug and like the rest of you I'm not getting any younger.
 
If Theralase had half a billion to spend every year none of us would have this opportunity, and the competition is going no where imho.  The standard of care is still scraping the bladder and BCG instillation, a procedure that my urologist described as barbaric.
 
If anyone is to blame for delays in getting BTD look to the FDA (big pharma) for changing the rules in mid stream.
 
Maybe Dr Lbiati has found an investor who will buy a large portion of this PP.  We won't know till next week.  I tend to think/hope the stock price hasn't declined since the PP was made public on this board because their might be a large investor who wants a big chunk.  If us small investors understand what the opportunity is here maybe there are wealthy investors who see the same as us.


Agree 100% 2b7...& very well said.

I also have to point my finger at the FDA as a big reason for much of the trial/enrollment delay.  I often wonder, does/did the FDA hold Big Pharma sponsors to the same clinical trial standards?  Did their data have to undergo the same central vetting requirements?  The FDA & Big Pharma are one in the same when the hands of Congress/FDA are constantly in the deep pockets of Big Pharma. JMO...

Well we live in Canada ! Were the heck is Health Canada  ? Always a follower never a leader . This treatment should already be available to patients whom need it in Canada IMHO and all whom wish to travel here. 
<< Previous
Bullboard Posts
Next >>